Announcements Trials

Browse Landscape

Phase

Status

Recruiting 2 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Specimen Handling 219 pembrolizumab 199 Magnetic Resonance Spectroscopy 197 Carboplatin 173 Cisplatin 139 Biopsy 133 Nivolumab 129 Paclitaxel 115 Radiotherapy 111 Cyclophosphamide 111 Gemcitabine 104 durvalumab 90 Dexamethasone 90 atezolizumab 76 Radiation 72 Rituximab 71 Lenalidomide 69 Pemetrexed 66 Doxorubicin 65 Bevacizumab 65 Docetaxel 62 Ipilimumab 58 Etoposide 57 olaparib 55 Fluorouracil 52 venetoclax 50 Taxes 50 Radiosurgery 50 Oxaliplatin 50 Prednisone 49

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × epigallocatechin gallate × 90 days × Clear all

NCT05364008 2026-03-23

FRIEND

Yale University

Phase 3 Active not recruiting

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡